|
1
|
Gershenwald JE, Scolyer RA, Hess KR,
Sondak VK, Long GV, Ross MI, Lazar AJ, Faries MB, Kirkwood JM,
McArthur GA, et al: Melanoma staging: Evidence-based changes in the
American joint committee on cancer eighth edition cancer staging
manual. CA Cancer J Clin. 67:472–492. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:12013. View Article : Google Scholar
|
|
3
|
Thompson JF, Soong SJ, Balch CM,
Gershenwald JE, Ding S, Coit DG, Flaherty KT, Gimotty PA, Johnson
T, Johnson MM, et al: Prognostic significance of mitotic rate in
localized primary cutaneous melanoma: An analysis of patients in
the multi-institutional American joint committee on cancer melanoma
staging database. J Clin Oncol. 29:2199–2205. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Temam S, Mamelle G, Marandas P, Wibault P,
Avril MF, Janot F, Julieron M, Schwaab G and Luboinski B:
Postoperative radiotherapy for primary mucosal melanoma of the head
and neck. Cancer. 103:313–319. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yu J, Luo X, Huang H, Zhai Z, Shen Z and
Lin H: Clinical characteristics of malignant melanoma in southwest
China: A single-center series of 82 consecutive cases and a
meta-analysis of 958 reported cases. PLoS One. 11:e01655912016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shoo BA and Kashani-Sabet M: Melanoma
arising in African-, Asian-, Latino- and Native-American
populations. Semin Cutan Med Surg. 28:96–102. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hao M, Zhao G, Du X, Yang Y and Yang J:
Clinical characteristics and prognostic indicators for metastatic
melanoma: Data from 446 patients in north China. Tumor Biol.
37:10339–10348. 2016. View Article : Google Scholar
|
|
8
|
Iacono D, Basile D, Gerratana L, Vitale
MG, Pelizzari G, Cinausero M, Poletto E, Puglisi F, Fasola G and
Minisini AM: Prognostic role of disease extent and
lymphocyte-monocyte ratio in advanced melanoma. Melanoma Res.
29:510–515. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Daneshmandi S, Wegiel B and Seth P:
Blockade of lactate dehydrogenase-a (LDH-A) improves efficacy of
anti-programmed cell death-1 (PD-1) therapy in melanoma. Cancers
(Basel). 11:E4502019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fanali G, di Masi A, Trezza V, Marino M,
Fasano M and Ascenzi P: Human serum albumin: From bench to bedside.
Mol Aspects Med. 33:209–290. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mittman N, Avram MM, Oo KK and
Chattopadhyay J: Prealbumin as an important predictor for survival
and nutritional status in hemodialysis and peritoneal dialysis
patients. Improving Prognosis for Kidney Disorders. Avram MM:
Springer; Dordrecht: pp. 61–67. 2002, View Article : Google Scholar
|
|
12
|
Fan L, Wang X, Chi C, Wang Y, Cai W, Shao
X, Xu F, Pan J, Zhu Y, Shangguan X, et al: Prognostic nutritional
index predicts initial response to treatment and prognosis in
metastatic castration-resistant prostate cancer patients treated
with abiraterone. Prostate. 77:1233–1241. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu DQ, Li FF and Jia WH: Cumulative
scores based on plasma D-dimer and serum albumin levels predict
survival in esophageal squamous cell carcinoma patients treated
with transthoracic esophagectomy. Chin J Cancer. 35:112016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Diao D, Wang Z, Cheng Y, Zhang H, Guo Q,
Song Y, Zhu K, Li K, Liu D and Dang C: D-dimer: Not just an
indicator of venous thrombosis but a predictor of asymptomatic
hematogenous metastasis in gastric cancer patients. PLoS One.
9:e1011252014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Batschauer AP, Figueiredo CP, Bueno EC,
Ribeiro MA, Dusse LM, Fernandes AP, Gomes KB and Carvalho MG:
D-dimer as a possible prognostic marker of operable hormone
receptor-negative breast cancer. Ann Oncol. 21:1267–1272. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kilic M, Yoldas O, Keskek M, Ertan T, Tez
M, Gocmen E and Koc M: Prognostic value of plasma D-dimer levels in
patients with colorectal cancer. Colorectal Dis. 10:238–241. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Altiay G, Ciftci A, Demir M, Kocak Z, Sut
N, Tabakoglu E, Hatipoglu ON and Caglar T: High plasma D-dimer
level is associated with decreased survival in patients with lung
cancer. Clin Oncol (R Coll Radiol). 19:494–498. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mirshahi SS, Pujade-Lauraine E, Soria C,
Mirshahi M, Fretault J, Bernadou A and Soria J: D-dimer and CA-125
levels in patients with ovarian cancer during antineoplastic
therapy. Prognostic significance for the success of anti-cancer
treatment. Cancer. 69:2289–2292. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ferrucci PF, Gandini S, Battaglia A,
Alfieri S, Di Giacomo AM, Giannarelli D, Cappellini GC, De Galitiis
F, Marchetti P, Amato G, et al: Baseline neutrophil-to-lymphocyte
ratio is associated with outcome of ipilimumab-treated metastatic
melanoma patients. Br J Cancer. 112:1904–1910. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schuurman MS, de Waal AC, Thijs EJM, van
Rossum MM, Kiemeney LALM and Aben KKH: Risk factors for second
primary melanoma among Dutch patients with melanoma. Br J Dermatol.
176:971–978. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Brożyna AA, Jóźwicki W, Roszkowski K,
Filipiak J and Slominski AT: Melanin content in melanoma metastases
affects the outcome of radiotherapy. Oncotarget. 7:17844–17853.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Brozyna AA, Jozwicki W, Carlson JA and
Slominski AT: Melanogenesis affects overall and disease-free
survival in patients with stage III and IV melanoma. Hum Pathol.
44:2071–2074. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Slominski A, Kim TK, Brożyna AA,
Janjetovic Z, Brooks DL, Schwab LP, Skobowiat C, Jóźwicki W and
Seagroves TN: The role of melanogenesis in regulation of melanoma
behavior: Melanogenesis leads to stimulation of HIF-1α expression
and HIF-dependent attendant pathways. Arch Biochem Biophys.
563:79–93. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gatta A, Verardo A and Bolognesi M:
Hypoalbuminemia. Intern Emerg Med. 7 (Suppl 3):193–199. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Moujaess E, Fakhoury M, Assi T, Elias H,
El Karak F, Ghosn M and Kattan J: The Therapeutic use of human
albumin in cancer patients' management. Crit Rev Oncol Hematol.
120:203–209. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li S, Xu H, Wu C, Wang W, Jin W, Gao H, Li
H, Zhang S, Xu J, Zhang W, et al: Prognostic value of
γ-glutamyltransferase-to-albumin ratio in patients with pancreatic
ductal adenocarcinoma following radical surgery. Cancer Med.
8:572–584. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Matsuda S, Takeuchi H, Kawakubo H, Fukuda
K, Nakamura R, Takahashi T, Wada N, Saikawa Y, Omori T and Kitagawa
Y: Cumulative prognostic scores based on plasma fibrinogen and
serum albumin levels in esophageal cancer patients treated with
transthoracic esophagectomy: Comparison with the glasgow prognostic
score. Ann Surg Oncol. 22:302–310. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Forrest LM, Mcmillan DC, Mcardle CS,
Angerson WJ and Dunlop DJ: Comparison of an inflammation-based
prognostic score (GPS) with performance status (ECOG) in patients
receiving platinum-based chemotherapy for inoperable non-small-cell
lung cancer. Br J Cancer. 90:1704–1706. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Desch A, Gebhardt C, Utikal J and
Schneider SW: D-dimers in malignant melanoma: Association with
prognosis and dynamic variation in disease progress. Int J Cancer.
140:914–921. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kwon HC, Oh SY, Lee S, Kim SH, Han JY, Koh
RY, Kim MC and Kim HJ: Plasma levels of prothrombin fragment F1+2,
D-dimer and prothrombin time correlate with clinical stage and
lymph node metastasis in operable gastric cancer patients. Jpn J
Clin Oncol. 38:2–7. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Deng W, Yu M, Ma H, Hu LA, Chen G, Wang Y,
Deng J, Li C, Tong J and Wang DX: Predictors and outcome of
patients with acute respiratory distress syndrome caused by miliary
tuberculosis: A retrospective study in Chongqing, China. BMC Infect
Dise. 12:1212012. View Article : Google Scholar
|
|
33
|
Datta M, Savage P, Lovato J and Schwartz
GG: Serum calcium, albumin and tumor stage in cutaneous malignant
melanoma. Future Oncol. 12:2205–2214. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang M and Zhang N: Clinical and
prognostic factors in 98 patients with malignant melanoma in China.
J Int Med Res. 45:1369–1377. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Raigani S, Cohen S and Boland GM: The role
of surgery for melanoma in an era of effective systemic therapy.
Curr Oncol Rep. 19:172017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Saranga-Perry V, Ambe C, Zager JS and
Kudchadkar RR: Recent developments in the medical and surgical
treatment of melanoma. Ca Cancer J Clin. 64:172–185. 2014.
View Article : Google Scholar
|
|
37
|
Flaherty KT, Puzanov I, Kim KB, Ribas A,
McArthur GA, Sosman JA, O'Dwyer PJ, Lee RJ, Grippo JF, Nolop K and
Chapman PB: Inhibition of mutated, activated BRAF in metastatic
melanoma. N Engl J Med. 363:809–819. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nestle FO, Alijagic S, Gilliet M, Sun Y,
Grabbe S, Dummer R, Burg G and Schadendorf D: Vaccination of
melanoma patients with peptide- or tumor lysate-pulsed dendritic
cells. Nat Med. 4:328–332. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Slominski AT and Carlson JA: Melanoma
resistance: A bright future for academicians and a challenge for
patient advocates. Mayo Clinic Proc. 89:429–433. 2014. View Article : Google Scholar
|
|
40
|
Huang K, Xu Y, Joseph R, Bagaria SP, Misra
S and Chen Y: Comparative analysis of acral melanoma in Chinese and
caucasian patients. Ann Surg Oncol. 26:S158–S159. 2019.
|
|
41
|
Huang YS, Chen XX, Yang SX, Wu LS, Zhao
JY, Li XY, Tu P and Li H: Preliminary exploration of the clinical
features of Chinese patients with skin malignancies and
premalignancies: A retrospective study of 1420 cases from peking
university first hospital. J Eur Acad Dermatol Venereol.
27:1114–1119. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Taylor AM, Shih J, Ha G, Gao GF, Zhang X,
Berger AC, Schumacher SE, Wang C, Hu H, Liu J, et al: Genomic and
functional approaches to understanding cancer aneuploidy. Cancer
Cell. 33:676–689.e673. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sanchez-Vega F, Mina M, Armenia J, Chatila
WK, Luna A, La KC, Dimitriadoy S, Liu DL, Kantheti HS, Saghafinia
S, et al: Oncogenic signaling pathways in the cancer genome atlas.
Cell. 173:321–337.e310. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Liu J, Lichtenberg T, Hoadley KA, Poisson
LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC, Levine DA, Lee
AV, et al: An integrated TCGA pan-cancer clinical data resource to
drive high-quality survival outcome analytics. Cell.
173:400–416.e411. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hoadley KA, Yau C, Hinoue T, Wolf DM,
Lazar AJ, Drill E, Shen R, Taylor AM, Cherniack AD, Thorsson V, et
al: Cell-of-origin patterns dominate the molecular classification
of 10,000 tumors from 33 types of cancer. Cell. 173:291–304.e296.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Gao Q, Liang WW, Foltz SM, Mutharasu G,
Jayasinghe RG, Cao S, Liao WW, Reynolds SM, Wyczalkowski MA, Yao L,
et al: Driver fusions and their implications in the development and
treatment of human cancers. Cell Rep. 23:227–238.e223. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ellrott K, Bailey MH, Saksena G, Covington
KR, Kandoth C, Stewart C, Hess J, Ma S, Chiotti KE, McLellan M, et
al: Scalable open science approach for mutation calling of tumor
exomes using multiple genomic pipelines. Cell Syst. 6:271–281.e277.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liang WS, Hendricks W, Kiefer J, Schmidt
J, Sekar S, Carpten J, Craig DW, Adkins J, Cuyugan L, Manojlovic Z,
et al: Integrated genomic analyses reveal frequent TERT aberrations
in acral melanoma. Genome Res. 27:524–532. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Berger MF, Hodis E, Heffernan TP, Deribe
YL, Lawrence MS, Protopopov A, Ivanova E, Watson IR, Nickerson E,
Ghosh P, et al: Melanoma genome sequencing reveals frequent PREX2
mutations. Nature. 485:502–506. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hodis E, Watson IR, Kryukov GV, Arold ST,
Imielinski M, Theurillat JP, Nickerson E, Auclair D, Li L, Place C,
et al: A landscape of driver mutations in melanoma. Cell.
150:251–263. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Krauthammer M, Kong Y, Ha BH, Evans P,
Bacchiocchi A, McCusker JP, Cheng E, Davis MJ, Goh G, Choi M, et
al: Exome sequencing identifies recurrent somatic RAC1 mutations in
melanoma. Nat Genetics. 44:1006–1014. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Van Allen EM, Wagle N, Sucker A, Treacy
DJ, Johannessen CM, Goetz EM, Place CS, Taylor-Weiner A, Whittaker
S, Kryukov GV, et al: The genetic landscape of clinical resistance
to RAF inhibition in metastatic melanoma. Cancer Discov. 4:94–109.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Hugo W, Zaretsky JM, Sun L, Song C, Moreno
BH, Hu-Lieskovan S, Berent-Maoz B, Pang J, Chmielowski B, Cherry G,
et al: Genomic and transcriptomic features of response to anti-PD-1
therapy in metastatic melanoma. Cell. 165:35–44. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Shain AH, Garrido M, Botton T, Talevich E,
Yeh I, Sanborn JZ, Chung J, Wang NJ, Kakavand H, Mann GJ, et al:
Exome sequencing of desmoplastic melanoma identifies recurrent
NFKBIE promoter mutations and diverse activating mutations in the
MAPK pathway. Nat Genetics. 47:1194–1199. 2015. View Article : Google Scholar : PubMed/NCBI
|
